Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals

Ann Hepatol. 2021 Mar-Apr:21:100141. doi: 10.1016/j.aohep.2019.08.012. Epub 2019 Oct 3.

Abstract

The association of Non-Hodgkin lymphomas and Hepatitis C virus is well documented and antiviral treatments facilitate a virological and hematological response in the majority of HCV related Non-Hodgkin lymphomas. The recent years, direct acting antivirals have made cure possible almost for every HCV patient. Some concerns were raised as regards the frequency and the pattern of recurrence in HCV patients with HCC, treated with these agents. We present a patient with DLBCL, in remission after appropriate treatment, HCV cirrhosis that was cured with the new antivirals and shortly after SVR, he experienced a lethal lymphoma recurrence.

Keywords: DAAs; HCC; HCV; NHL.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Biopsy
  • Hepacivirus / isolation & purification*
  • Humans
  • Liver / diagnostic imaging*
  • Liver / virology
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / virology
  • Lymphoma, Large B-Cell, Diffuse / diagnosis
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / virology
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography
  • Sustained Virologic Response

Substances

  • Antiviral Agents